Kohjin Bio Co.,Ltd.
Code | Sector | Market |
---|---|---|
177A | Chemicals | Growth |
Date of listing approval | 2024/03/22 |
---|---|
Expected Date | 2024/04/25 |
Lead Underwriter | Nomura |
Description |
Listed Shares(total) | 977,500 |
---|---|
Trading Unit | 100 |
New Shares | 850,000 |
Existing Shares | 127,500¡Êonly O.A.¡Ë |
Shares Outstanding | PreIPO 4,165,000.00 |
PostIPO 5,015,000.00 | |
Paid Up Capital | PreIPO Y426,656,000 |
PostIPO Y1,169,556,000 | |
Expected Pricing Date | 2024/04/05 |
Book Building Start | 2024/04/09 |
Book Building End | 2024/04/15 |
Fix Date | 2024/04/16 |
Offering Starts | 2024/04/17 |
Offering Ends | 2024/04/22 |
Expect Pricing | Y1,840-Y1,900 |
Notional PER (based on previous period) |
9.24-9.54 |
Notional PER(based on results forecast) | 26.50-27.37 |
Offering Price | Y1,900 |
Offering Price PER (based on previous period) |
26.50-27.37 |
Offering Price PBR (based on previous period) |
2.62 |
Offering Price PER (based on results forecast) |
27.37 |
Use of Funds Raised |
Financial Data
Units:Y1,000
Fiscal Year End:2021/03 | ||
---|---|---|
Consolidated | Non-consolidated | |
Revenue | - | 3,251,321 |
Current Profit | - | 665,762 |
Net Profit | - | 685,074 |
Net Assets | - | 1,418,904 |
Fiscal Year End:2022/03 | ||
---|---|---|
Consolidated | Non-consolidated | |
Revenue | 3,947,089 | 3,622,295 |
Current Profit | 917,837 | 841,840 |
Net Profit | 587,675 | 564,269 |
Net Assets | 2,216,895 | 2,002,942 |
Fiscal Year End:2023/03 | ||
---|---|---|
Consolidated | Non-consolidated | |
Revenue | 4,742,992 | 4,406,871 |
Current Profit | 1,244,391 | 1,116,671 |
Net Profit | 829,790 | 751,221 |
Net Assets | 3,017,830 | 2,712,308 |
Recent Quarter 2023/12 |
||
---|---|---|
Consolidated | Non-consolidated | |
Revenue | 3,544,575 | - |
Current Profit | 397,839 | - |
Net Profit | 207,138 | - |
Net Assets | 3,184,261 | - |
Results Forecast 2024/03 |
||
---|---|---|
Consolidated | Non-consolidated | |
Revenue | 4,724,000 | - |
Current Profit | 560,000 | - |
Net Profit | 289,000 | - |
Net Assets | - | - |
Per Share Units:Y1
Fiscal Year End:2021/03 | ||
---|---|---|
Consolidated | Non-consolidated | |
Dividend | 10.00 | |
Net Earning | - | - |
Equity | 202.39 | 412.20 |
Fiscal Year End:2022/03 | ||
---|---|---|
Consolidated | Non-consolidated | |
Dividend | 10.00 | |
Net Earning | 173.50 | 532.27 |
Equity | 166.59 | 480.90 |
Fiscal Year End:2023/03 | ||
---|---|---|
Consolidated | Non-consolidated | |
Dividend | 19.00 | |
Net Earning | 199.23 | 724.57 |
Equity | 180.37 | 651.21 |
Fiscal Year End:Recent Quarter 2023/12 |
||
---|---|---|
Consolidated | Non-consolidated | |
Dividend | ||
Net Earning | 49.73 | - |
Equity | - | - |
Fiscal Year End:Results Forecast 2024/03 |
||
---|---|---|
Consolidated | Non-consolidated | |
Dividend | 14.00 | |
Net Earning | 69.43 | - |
Equity | - | - |
Comment
¢£Over allotment(127,500) |
Consolidated Subsidiaries
Name | Address |
---|
Underwriters
Allocation | Underwriter | Tel |
---|---|---|
0% | Nomura | 03-3211-1811 |
90% | Nomura | 03-3211-1811 |
3% | Mizuho | 03-5208-3210 |
3% | SMBC Nikko | 03-5644-3111 |
3% | Musashi Securities Co.,Ltd | 048-644-0634 |
1% | SBI SECURITIES Co.,Ltd. | 03-5562-7210 |
Data
Date of incorporation | 1981/04/20 |
---|---|
Company address | Saitama 350-0214 |
Telephone | 049-284-3781 |
President | |
Homepage | https://kohjin-bio.jp/ |
Auditor | Azsa |
Major Shareholders | |
---|---|
Shareholder Name | Ratio |
86.62% | |
53.05% | |
10.00% | |
6.48% | |
4.23% | |
3.36% | |
2.88% | |
2.40% | |
2.40% | |
2.40% | |
1.92% |
Number of Employees | 133 as of 2024/02/29 |
---|---|
Birth Date of Representative | 1949/05/23 |